ANUHPHR vs FABTECH: Stock Comparison

Anuh Pharma Limited vs Fabtech Technologies Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Anuh Pharma Limited is the larger company by market capitalisation. Anuh Pharma Limited shows a higher dividend yield, lower leverage and a higher ROCE, while Fabtech Technologies Limited shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Anuh Pharma Limited and Fabtech Technologies Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ANUHPHR is more favourable on 3 of 13 scored metrics and FABTECH on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
ANUHPHR is the larger company
₹793 Cr vs ₹663 Cr
P/E Ratio
FABTECH has a lower P/E
13.79x vs 19.37x
P/B Ratio
FABTECH has a lower P/B
1.6x vs 2.26x
EPS
FABTECH has higher earnings per share
₹10 vs ₹4.1
Dividend Yield
ANUHPHR has a higher dividend yield
1.87% vs 0%
Revenue Growth (TTM YoY)
FABTECH has faster revenue growth
17.5% vs 2%
EPS Growth (TTM YoY)
FABTECH has faster EPS growth
23.4% vs -6%
Qtr Sales Growth
FABTECH has stronger quarterly sales growth
17.5% vs 2.01%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricANUHPHRFABTECH
SectorHealthcareHealthcare
IndustryPharmaceuticalsMedical Equipment & Supplies

Price

MetricANUHPHRFABTECH
Live Price₹79.07₹149.73
Day Change-0.48%0.76%
Volume17,3421.93 L
52-Week High₹101.7₹262.8
52-Week Low₹67₹132.7
Distance from 52W High-22.25%-43.03%

Valuation

MetricANUHPHRFABTECH
Market Cap₹793 Cr₹663 Cr
P/E Ratio19.37x13.79x
P/B Ratio2.26x1.6x
EPS₹4.1₹10
Book Value₹35.28₹109.44
Dividend Yield1.87%0%

Growth

MetricANUHPHRFABTECH
Revenue Growth (TTM YoY)2%17.5%
EPS Growth (TTM YoY)-6%23.4%
Qtr Sales Growth2.01%17.5%
Qtr Profit Growth-6.26%46.2%

Profitability & Leverage

MetricANUHPHRFABTECH
ROE12.1%12.5%
ROCE15.9%13.6%
Net Margin5.32%11.28%
Operating Margin8%8.52%
Debt to Equity0x0.17x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricANUHPHRFABTECH
Promoter Holding71.78% 0.02 pp68.94%
FII Holding0.05% 0.05 pp0.02% 0.06 pp
DII Holding0%2.45% 0.3 pp
Public Holding28.16% 0.02 pp28.58% 0.25 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Anuh Pharma Limited and Fabtech Technologies Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.